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We investigated the effect of oral administration of the herb, Scoparia dulcis, on Trypanosoma brucei-
induced changes in plasma lipid profile in rabbits over a period of twenty eight days. Results obtained 
show that infection with T. brucei resulted in significant increases in plasma total cholesterol, 
trriacylglycerol, and low density lipoprotein (LDL)-cholesterol, while the level of high density lipoprotein 
(HDL)-cholesterol was also significantly reduced. Further comparative analysis of data revealed that 
these lesions were significantly less severe (p<0.05), in the infected and treated group relative to their 
untreated counterparts. However, the precise mechanism underlying the plasma lipid modulating 
effects of the herb is still a matter of speculations. 
 





Scoparia dulcis or sweet broom weed is an erect annual 
herb with serrated leaves, producing white flowers and 
measuring up to a half meter in height when fully grown. 
In view of its high reputation and wide acceptance in 
ethnomedicine, this plant has attracted not only wide 
publicity but also intensified research efforts by 
researchers (Branch and daSilva, 1983; Denis, 1988.). 
More recently, a number of the speculated medicinal 
values of S. dulcis have been validated by scientific 
research. These include hypoglycemic activity (Jain, 
1985; Latha et al., 2004a, 2004b; Pari and 
Venkateswaran, 2002; Pari and Latha., 2005), antitumour 
promoting activity (Nishino, 1993), and antiviral activity 
(Hayashi, 1990). Ratnasooriya et al. (2003) has also 
demonstrated a significant analgesic and 
antihyperalgesic activity for S. dulcis decoction. 
Phytochemical screening of the herb revealed that it is 
rich in flavonoids and terpenes and the pharmacological 
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presence of these phytochemicals (Hayashi, 1987, 1990, 
1991; Kawasaki, 1987; Ahmed and Jakupovic, 1990). The 
present research interest/effort arose from the widely 
speculated efficacy of S. dulcis in the management of 
sickle cell anaemia in parts of Nigeria. Mrs. Hilda Ogbe 
has for over two decades employed the herb in the 
management of sickle cell anaemia with profoundly 
outstanding results. There were claims of massive boost 
in haematocrit or packed cell volume (PCV) and 
haemoglobin (Hb) levels, as well as some degree of 
amelioration of the frequent crisis associated with the 
disorder. The lack of animal model for sickle cell disease 
prompted us to investigate the efficacy of S. dulcis using 
animal models experimentally infected with Trypanosoma 
brucei brucei. Progressive anaemia is widely accepted as 
a cardinal feature of T. brucei brucei infection (Moulton 
and Sollod, 1976; Suliman and Feldman, 1989). The 
compelling evidence in favour of the anti-anaemic claim 
prompted us to investigate the effect of S. dulcis on 
selected T. brucei-induced biochemical and 
haematological lesions in the rabbit. The present report 
summarizes our findings on the efficacy of S. dulcis in the 
management of trypanosome associated dyslipidaemia, 
characterized by  elevated  plasma  cholesterol,  elevated  




triacylglycerol, elevated LDL cholesterol and depressed 
HDL cholesterol level. 
 
 
MATERIALS AND METHOD 
 
Treatment of animals 
 
Fifteen (15) New Zealand white rabbits (average weight = 1.50 kg) 
obtained from a private farm in Benin City were used for the 
experiment. These were randomly divided into 3 groups of n = 5 
with each group allowed a 14 days acclimatization on growers 
mash (product of Bendel Feeds and flour Mill Ewu, Edo State, 
Nigeria) prior to the commencement of experiment. Group 1 served 
as control while groups II and III were inoculated with T. brucei 
brucei. Inoculation was by intraperitoneal injection of 0.5 ml of a 1:1 
(infected whole blood: normal saline) preparation, and with each 
inoculum containing about 2 x 106 of the parasite. Parasite 
estimation was by the rapid “Matching” method (Herbert and 
Lumbsden, 1976). The original stock of T. brucei was obtained from 
the Nigerian Institute for Trypanosomiasis Research, Vom, Plateau 
State, Nigeria. The control animals (Group 1) were each given 
intraperitoneal injection of 0.5 ml of normal saline in lieu of parasite. 
All animals were allowed unlimited access to food and clean 
drinking water throughout the duration of the experiment. In addition 
the inoculated and treated animals (group II) were given S. dulcis at 
a daily oral dose of 25 mg/kg body weight. Preparation of S. dulcis 
involved only air drying and blending of the entire shoot system. 
The required weight of pulverized S. dulcis was administered as an 
aqueous suspension in clean drinking water, through gavage. Blood 
samples were collected prior to infection on day 0 and analyzed for 
baseline data. Subsequent data obtained on days 7, 14, 21 and 28 
were compared with these pre-infection values. In addition, 
comparisms were also made across groups to evaluate the extent 
of trypanosome-induced changes as well as the degree of S. dulcis-
mediated amelioration. For the avoidance of doubt, blood samples 
were collected after an overnight fast, and in heparinized sample 
bottles. The resultant plasma obtained after centrifugation at 2,500 






The determination of plasma lipids namely, total cholesterol, 
triacylglycerol, and the lipoproteins (HDL and LDL cholesterol) were 
carried out using previously described protocols, and by means of 
commercially available test kits (products of Randox laboratories, 
U.K). In all instances, the manufacturer’s instructions were strictly 
adhered to.  
                                
              
Statistical analysis 
  
The group Mean ± S.E.M. was calculated for each analyte and 
significant difference between means evaluated by analysis of 
variance (ANOVA). Post test analysis was done using the Tukey-
Krammer multiple comparism tests. Values of p<0.05 were 
considered as statistically significant. 
 
 
RESULTS AND DISCUSSION 
 
The results obtained in this study are presented in Tables 
1 to 4. Values are expressed as mean ± S.E.M. There 





plasma triacylglycerol, total cholesterol and LDL 
cholesterol in infected animals when compared with 
controls. HDL cholesterol levels were however 
significantly lower (p<0.05) in infected animals relative to 
controls. 
African trypanosomes are lipid auxotrophs that live in 
the blood stream of their mammalian host, and 
exogenous lipids play essential roles in the parasite’s cell 
structure and metabolism. Their requirement for 
lipoproteins as an essential growth factor is now well 
established. However, lipoproteins that are devoid of their 
lipid components are ineffective in maintaining the growth 
of trypanosomes. These parasites find ready sources of 
lipids namely cholesterol esters, cholesterol and 
phospholipids in the plasma lipoproteins, LDL and HDL 
(Coppens et al., 1987; Gillet and Owen, 1992). 
Trypanosomes lack ability for the de novo synthesis of 
fatty acids (myristate being an exception) and yet require 
lipid for the biosynthesis of glycosylated phosphatidyl-
inositol anchors (Morita et al., 2000; Paul et al., 2001). 
The parasite induced hyperlipidaemia is believed to be 
somewhat related to its compulsory requirement for 
lipids. There is now compelling evidence for the existence 
of a trypanosome lipoprotein scavenger receptor that is 
believed to facilitate the endocytosis of both native and 
modified lipoproteins, including HDL and LDL (Green et 
al., 2003). There are also indications that altered plasma 
levels of these lipids (total cholesterol, LDL cholesterol, 
HDL cholesterol and triacylglycerol) may raise the risk of 
cardiovascular complications in the mammalian host 
particularly during chronic infection. 
It is known that aberrations in the levels of plasma 
lipids and lipoprotein contribute significantly to the 
aetiology of arteriosclerosis and associated 
cardiovascular disorders (Hajjar and Nicholson, 1995; 
Olson, 1998; Mayne, 1994; Wallach, 1996).  
Atherosclerosis could be considered as the distortion and 
obstruction of the artery resulting from the calcification 
and ulceration of atheromatous plaques. The lesion is 
often accompanied with the proliferation of intima smooth 
muscle cells, massive accumulation of macrophages and 
formation of large amount of connective tissues by the 
proliferated cells. Accumulation of lipids, notably free and 
esterified cholesterol within the cell, and in the 
surrounding connective tissues is also a cardinal feature 
of the disorder (Ross and Glomset, 1973, 1976; Ross 
and Harker, 1976; Wisserler et al., 1976). 
There is a positive correlation between the risk of 
developing ischaemic heart disease and raised levels of 
total and esterified cholesterol in plasma. Several studies 
have revealed that the lesions of arteriosclerosis are 
secondary to endothelial dysfunction occasioned by such 
factors as elevated and modified LDL, hypertension, 
diabetes mellitus, cigarette smoking amongst others 
(Ross and Glomset, 1976; Ross, 1981, 1986, 1993). 
Chronically elevated levels of LDL cholesterol lead to an 
increase in the number  of  cholesterol  molecules  in  the  




           Table 1. Effect of Scoparia dulcis on Trypanosomia brucei-induced hypercholesterolaemia. 
 
Plasma total  cholesterol concentration (mg/dL) Group 
Day 0 Day 7 Day 14 Day 21 Day 28 
Control 114.76 ± 2.47a 116.87 ± 3.14a 120.67 ± 2.82a 118.46± 3.135a 120.19 ±4.01 a 
Inoculated treated 112.48 ± 1.98a 120.52 ± 2.11a 130.72  ± 2.63b 128.98 ± 2.12b 142.68 ± 4.39 b 
Inoculated untreated 116.12 ± 2.09a a 115.24 ± 2.06a 138.75 ± 3.61c 143.60 ± 3.25c 176.38 ± 8.162 c 
 
Values are Mean ± S.E.M., and values on the same column with different superscript differ significantly (p<0.05). 
 
 
Table 2. Effect of Scoparia dulcis on Trypanosomia brucei-induced hypertriglyceridaemia. 
 
Plasma triacylglycerol concentration (mg/dL) Group 
Day 0 Day 7 Day 14 Day 21 Day 28 
Control 122.85 ±    5.06 a 126.43 ± 3.12a 131.33  ± 4.39a 128.16 ± 3.40a 130.49 ±3.81a 
Inoculated treated 126.08 ± 3.64a 132.41 ± 3.41a 204.19 ± 6.02b 215.60 ± 7.13b 242.65 ± 6.83b 
Inoculated untreated 127.54 ±  4.14 a 131.42 ± 3.82a 236.15 ± 6.86c 284.07± 8.82c 308.112 ± 7.71c 
 




Table 3. Effect of Scoparia dulcis on Trypanosomia brucei-induced decrease in HDL cholesterol concentration. 
 
Plasma HDL-cholesterol concentration (mg/dL) Group 
Day 0 Day 7 Day 14 Day 21 Day 28 
Control 60.15 ±    3.41a 56.34 ± 3.87a 63.37 ± 4.19a 61.43 ± 3.44a 64.22 ±2.87a 
Inoculated treated 58.62 ± 3.71a 63.42 ± 2.27a 52.74 ± 2.700 a, c           48.85± 3.5 b, c 56.14 ± 2.21a 
Inoculated untreated 62.39 ±  4.00 a 60.18 ± 3.61a 49.78 ± 3.12 b, c 43.46 ± 2.46c 40.36 ± 3.72 b 
 
Values are Mean ± S.E.M and values on the same column with different superscript differ significantly (p<0.05). Significant 
difference between treated and untreated animals was recorded only on day 28 post infection. 
 
 
Table 4. Effect of Scoparia dulcis on Trypanosomia brucei-induced elevation in LDL cholesterol concentration. 
 
Plasma HDL-cholesterol concentration (mg/dL) Group 
Day 0 Day 7 Day 14 Day 21 Day 28 
Control 30.09 ± 1.64a 35.24 ± 1.98a 31.04 ± 2.11a 31.43 ± 2.02a 29.87 ±2.11a 
Inoculated treated 28.64 ± 2.20a 30.62 ± 1.05a 37.15 ± 2.12a, c 37.01± 3.5 a, c 38.01 ± 2.11a 
Inoculated untreated 28.23 ±1.85a 32.78 ± 1.63a 41.73 ± 2.01b, c 43.46 ± 2.63 b, c 74.40 ± 3.81b 
 
Values are Mean ± S.E.M and values on the same column with different superscript differ significantly (p<0.05). Significant difference 
between treated and untreated animals was recorded only on day 28 post infection. 
 
 
plasma membrane. The result is an increase in the 
cholesterol: phospholipid ratio of the membrane. The 
increased viscosity and thus decreased malleability of the 
endothelial membrane has been speculated to be the 
primary potentiating factor in the aetiology of 
atherosclerosis (Jackson and Gotto, 1976). It has been 
suggested that oxidized LDL is injurious to endothelium 
and smooth muscle in vitro (Boyd et al., 1976; Steingerg, 
1997). Once trapped in the artery, LDL particles undergo 
oxidation and subsequent receptor mediated internali-
zation by macrophages. The result is the formation of 
lipid peroxides, accumulation of cholesteryl esters and 
formation of foam cells (Khoo et al., 1988, 1992; Morel et 
al., 1983; Griendling and Alexander, 1997; Han et al., 
1997). Thus a rational approach to preventing the 
incidence of atherosclerosis should include reduction in 
LDL levels, prevention of LDL oxidation or both. 
Several epidemiological and clinical studies have 
suggested a link between elevated triacylglycerol and 
increased cardiovascular risk (Austin, 1988; Carlson and 
Bottiger, 1985). It has been suggested also that the link 
between elevated triacylglycerol and cardiovas-cular 
complications may be secondary to other diseases 
(Kaplan, 1989). A number of conditions that are 
associated with elevated plasma triacylglycerol such as 
diabetes mellitus and renal failure are known to be  asso- 




ciated with increased risk of cardiovascular 
complications. 
HDL particles are responsible for the reverse transport 
of free cholesterol from peripheral tissues by way of a 
putative HDL receptor (Mayne, 1994). This receptor 
mediated reverse transport may explain why patients with 
elevated HDL concentration are less prone to coronary 
artery disease (Krieger, 1999). Rational management of 
hypercholesterolaemia are geared towards reducing 
plasma total cholesterol, LDL cholesterol and triacylgly-
cerol, while increasing the proportion of HDL cholesterol 
(Olson, 1998; Kane, 1986; Spady, 1993). 
As mentioned earlier, infection with Trypanosoma 
brucei is accompanied by a mixed type hyperlipidaemia 
characterized by abnormal plasma lipid and lipoprotein 
levels. Total cholesterol, LDL cholesterol and triacylgly-
cerol are highly elevated while the HDL: total cholesterol 
and HDL: LDL cholesterol ratios are depressed in 
infected animals relative to control. The ability of S. dulcis 
to mitigate against these plasma lipid anomalies is 
underscored in the present study The level of total 
cholesterol, LDL cholesterol and triacylglycerol in treated 
animals were significantly lower (p<0.05) relative to the 
infected but untreated group. Furthermore, the parasite-
induced decrease in HDL cholesterol was also 
significantly resisted in the treated group, thus enhancing 
the HDL: total cholesterol and the HDL: LDL ratios. This 
phenomenon no doubt favours a reduction in 
cardiovascular risk. While the exact mechanism by which 
S. dulcis achieves this feat is not immediately apparent, it 
seems logical to speculate that the putative mechanism 
may revolve around reduction in parasite load or the 
control of the induced dyslipidaemia by means that are 
independent of any possible trypanocidal activity of S. 
dulcis. This and many more aspects require further 
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